Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Medigene AG to report full year 2023 financial results on March 28, 2024 | ||||||||||||
By: GlobeNewswire - 18 Mar 2024 | Back to overview list |
|||||||||||
Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will report financial results and provide a corporate update for the fiscal year ended December 31, 2023, on Thursday, March 28, 2024. Following the release of the full year 2023 earnings results and annual report on Medigene’s website, the Company will host a conference call that same day at 3 pm CET / 10 am ET. Full details for the conference call and webcast are as follows:
Participants may pre-register and will receive dedicated dial-in details to easily and quickly access the call with the above registration link for the conference call. Please dial in 10 minutes ahead of time to ensure a timely start of the conference call. Following the call, an archived webcast will be accessible on the Investors & Media section on Medigene’s website: https://medigene.com/investors-media/reports-presentations/ --- end of press release --- About Medigene AG Medigene AG In case you no longer wish to receive any information about Medigene, please inform us by e-mail (investor@medigene.com). We will then delete your address from our distribution list. |
||||||||||||
|
||||||||||||
Copyright 2024 GlobeNewswire | Back to overview list |